With pos­i­tive PhII NASH da­ta in tow, Akero opens $175M pub­lic of­fer­ing

It didn’t take long for Akero Ther­a­peu­tics to open up a pub­lic of­fer­ing af­ter un­veil­ing mid-stage clin­i­cal da­ta that sent its stock soar­ing to its high­est price in over a year.

De­tails are scant, but with Akero’s mar­ket cap now at more than $1 bil­lion, we know that Akero is seek­ing $175 mil­lion via an un­der­writ­ten pub­lic of­fer­ing of shares of its com­mon stock, trad­ing un­der the tick­er $AKRO. Un­der­writ­ers get 30 days to snatch up an­oth­er $26.25 mil­lion in shares.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER